Findings

What do systematic reviews say?

4 questions · 4 findings · 1 reviews

No studies found 2 · 50%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 50%Moderate 0 · 0%High 0 · 0%

Graft thrombosis (up to 3 months) · people with ESRD receiving haemodialysis through an arteriovenous fistula or graft

Sulphinpyrazone showed no clear difference in graft thrombosis (up to 3 months) compared with placebo (low certainty).

1 finding from 1 review

Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts 2021 · Cochrane Headline outcomes only
OR 0.43 [0.03, 5.98]
1 study · 16 participants
Low

Length of hospital stay · people with ESRD receiving haemodialysis through an arteriovenous fistula or graft

The review found no eligible studies for this question.

1 finding from 1 review

Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Complications (up to 3 months) · people with ESRD receiving haemodialysis through an arteriovenous fistula or graft

1 finding from 1 review

Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Low

Number of related surgical or radiological interventions · people with ESRD receiving haemodialysis through an arteriovenous fistula or graft

The review found no eligible studies for this question.

1 finding from 1 review

Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found